TGA Approval

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection pre-filled syringe (297644)

ARTG ID

297644

ARTG Name

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection pre-filled syringe

Sponsor

Lundbeck Australia Pty Ltd

ARTG Date

May 7, 2018

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Lundbeck Australia Pty Ltd

Sponsor Item Name

LUNDBECK AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

aripiprazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection pre-filled syringe (297644) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

ABILIFY MAINTENA aripiprazole (as monohydrate) 400 mg powder and solvent for prolonged release suspension for injection pre-filled syringe (297644)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal